Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Addiction Biomarkers: Dimensional Approaches to Understanding Addiction.

Literature DB >> 29307501

Addiction Biomarkers: Dimensional Approaches to Understanding Addiction.

Laura E Kwako¹, Warren K Bickel², David Goldman³.

Abstract

Trends towards dimensional approaches in understanding psychiatric disorders may also be applied to addictive disorders. Advances in our understanding of the neurobiology of addiction can inform these efforts. Furthermore, dimensional approaches to addiction, such as the proposed Addictions Neuroclinical Assessment (ANA), may be used in identifying novel addiction biomarkers, and refining ones that currently exist. These biomarkers, derived from both an understanding of the neurobiology of addiction and behavioral phenotypes, represent a departure from traditional markers of alcohol-relevant biomarkers, such as tests of liver function (LFTs). We posit that a potential addiction-relevant biomarker is reinforcer pathology, found to be relevant across addictions to different substances, and which may offer a target for modification through the use of episodic future thinking.

Entities: Chemical Disease Gene Species

Keywords: addiction; biomarkers; nosology

Mesh：

Substances：
Biomarkers

Year: 2018 PMID： 29307501 PMCID： PMC6233300 DOI： 10.1016/j.molmed.2017.12.007

Source DB: PubMed Journal: Trends Mol Med ISSN： 1471-4914 Impact factor: 11.951

40 in total

1. Mild opioid deprivation increases the degree that opioid-dependent outpatients discount delayed heroin and money.

Authors: Louis A Giordano; Warren K Bickel; George Loewenstein; Eric A Jacobs; Lisa Marsch; Gary J Badger
Journal: Psychopharmacology (Berl) Date: 2002-07-13 Impact factor: 4.530

2. Episodic future thinking reduces reward delay discounting through an enhancement of prefrontal-mediotemporal interactions.

Authors: Jan Peters; Christian Büchel
Journal: Neuron Date: 2010-04-15 Impact factor: 17.173

3. Endophenotype, intermediate phenotype, biomarker: definitions, concept comparisons, clarifications.

Authors: Mark F Lenzenweger
Journal: Depress Anxiety Date: 2013-01-16 Impact factor: 6.505

Review 4. The behavioral- and neuro-economic process of temporal discounting: A candidate behavioral marker of addiction.

Authors: Warren K Bickel; Mikhail N Koffarnus; Lara Moody; A George Wilson
Journal: Neuropharmacology Date: 2013-06-24 Impact factor: 5.250

5. Which alcohol use disorder criteria contribute to the association of ADH1B with alcohol dependence?

Authors: Amy B Hart; Kevin G Lynch; Lindsay Farrer; Joel Gelernter; Henry R Kranzler
Journal: Addict Biol Date: 2015-04-01 Impact factor: 4.280

6. Reinforcer Pathology: The Behavioral Economics of Abuse Liability Testing.

Authors: W K Bickel; S E Snider; A J Quisenberry; J S Stein
Journal: Clin Pharmacol Ther Date: 2016-09-19 Impact factor: 6.875

Review 7. Toward Narrative Theory: Interventions for Reinforcer Pathology in Health Behavior.

Authors: Warren K Bickel; Jeffrey S Stein; Lara N Moody; Sarah E Snider; Alexandra M Mellis; Amanda J Quisenberry
Journal: Nebr Symp Motiv Date: 2017

Review 8. Addictions Neuroclinical Assessment: A Neuroscience-Based Framework for Addictive Disorders.

Authors: Laura E Kwako; Reza Momenan; Raye Z Litten; George F Koob; David Goldman
Journal: Biol Psychiatry Date: 2015-11-17 Impact factor: 13.382

9. Reduced hedonic capacity in major depressive disorder: evidence from a probabilistic reward task.

Authors: Diego A Pizzagalli; Dan Iosifescu; Lindsay A Hallett; Kyle G Ratner; Maurizio Fava
Journal: J Psychiatr Res Date: 2008-04-22 Impact factor: 4.791

10. Prospective memory and future event simulation in individuals with alcohol dependence.

Authors: Alison Griffiths; Robert Hill; Celia Morgan; Peter G Rendell; Khashayar Karimi; Shamil Wanagaratne; H Valerie Curran
Journal: Addiction Date: 2012-07-12 Impact factor: 6.526

30 in total

1. Regional differences in white matter integrity in stimulant use disorders: A meta-analysis of diffusion tensor imaging studies.

Authors: Charlotte L Beard; Joy M Schmitz; Heather E Soder; Robert Suchting; Jin H Yoon; Khader M Hasan; Ponnada A Narayana; F Gerard Moeller; Scott D Lane
Journal: Drug Alcohol Depend Date: 2019-05-29 Impact factor: 4.492

Review 2. Is Subtyping of Gamblers Based on the Pathways Model of Problem and Disordered Gambling Valid? A Systematic Review.

Authors: Adam Kurilla
Journal: J Gambl Stud Date: 2021-01-01

3. Not all drugs are created equal: impaired future thinking in opiate, but not alcohol, users.

Authors: Ahmed A Moustafa; Alejandro N Morris; Jean Louis Nandrino; Błażej Misiak; Monika Szewczuk-Bogusławska; Dorota Frydecka; Mohamad El Haj
Journal: Exp Brain Res Date: 2018-08-11 Impact factor: 1.972

4. Cortisol as a Biomarker of Alcohol Use in Combat Veterans: A Literature Review and Framework for Future Research.

Authors: Yvette Z Szabo; Tessa Breeding; Christina Hejl; Rakeshwar S Guleria; Steven M Nelson; Laura Zambrano-Vazquez
Journal: J Dual Diagn Date: 2020-06-04

5. Impaired frontostriatal functional connectivity among chronic opioid using pain patients is associated with dysregulated affect.

Authors: Patrick A McConnell; Eric L Garland; Jon-Kar Zubieta; Roger Newman-Norlund; Shannon Powers; Brett Froeliger
Journal: Addict Biol Date: 2019-04-04 Impact factor: 4.280

6. Escalation of drug use in persons dually diagnosed with opioid and cocaine dependence: Gender comparison and dimensional predictors.

Authors: Eduardo R Butelman; Carina Y Chen; Kate G Brown; Mary Jeanne Kreek
Journal: Drug Alcohol Depend Date: 2019-10-22 Impact factor: 4.492